Reversion of Severe XXXX in @entity296 Using @entity6759 .

@entity1 @entity712 @entity296 @entity339 @entity452 @entity1353 @entity1283 @entity384 @entity409 @entity120 @entity591 @entity997 @entity6759 @entity299 @entity1002
UNASSIGNED: @entity296 presenting with @entity712 is a true diagnostic and treatment challenge. Goal oriented clinical management aims at the relapse of @entity1002 . A 35-year-old @entity1 on her 12th day post-delivery presents progressive signs of @entity712 . Transthoracic echocardiography showed severe @entity339 , mild @entity1002 , mild @entity997 , severe @entity120 , and right @entity1283 . With wet and cold @entity712 signs, the @entity1 was a candidate for inodilator cardiovascular support and volume depletion therapy. As the @entity1 presented a persistent @entity591 at rest, @entity6759 was chosen over @entity452 . @entity6759 was administered at a dose of 0.2   g/kg/min during a period of 24 hours. After inodilator therapy, the @entity1 's signs and symptoms of @entity712 began to decrease, showing improvement of @entity1353 , mitral murmur grade went from IV/IV to II/IV, filling pressures and systemic and pulmonary resistance indexes decreased, arterial blood gases improved, and an echocardiography performed 72 h later showed @entity384 , mild @entity299 , mild @entity339 and improvement of @entity120 . Cardiovascular function in peripartum @entity296 tends to go back to normality in 23-41% of the cases, but in a large group of @entity1 , severe @entity409 remains months after initial symptoms. This article describes the diagnostic process of a @entity1 with peripartum @entity296 and a successful reversion of a severe case of @entity339 using @entity6759 as a new therapeutic strategy in this clinical context.
